O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+30.47%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.45B
AUM Growth
+$5.45B
(+9.1%)
Cap. Flow
-$287M
Cap. Flow
% of AUM
-5.27%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
130
New
20
Increased
22
Reduced
29
Closed
17
Top Buys
| 1 |
ArriVent BioPharma
AVBP
|
$54.1M |
| 2 |
Cytokinetics
CYTK
|
$47.9M |
| 3 |
Geron
GERN
|
$40.9M |
| 4 |
Q32 Bio
QTTB
|
$38.4M |
| 5 |
Esperion Therapeutics
ESPR
|
$36.7M |
Top Sells
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Invivyd
IVVD
$204M
| $11.9M | 0.22% | 2,690,300 -1,437,265 | -35% | -$6.38M |
|
77
PMV Pharmaceuticals
PMVP
$74.2M
| $11M | 0.2% | 6,475,291 | – | – |
|
78
Ventyx Biosciences
VTYX
$171M
| $10.3M | 0.19% | +1,870,456 | New | +$10.3M |
|
79
Fate Therapeutics
FATE
$120M
| $9.95M | 0.18% | 1,355,352 +827,272 | +157% | +$6.07M |
|
80
X4 Pharmaceuticals
XFOR
$84.2M
| $9.92M | 0.18% | 7,133,515 | – | – |
|
81
Exact Sciences
EXAS
$8.98B
| $9.7M | 0.18% | +140,400 | New | +$9.7M |
|
82
Cullinan Oncology
CGEM
$445M
| $8.82M | 0.16% | 517,606 -27,242 | -5% | -$464K |
|
83
Nkarta
NKTX
$151M
| $8.65M | 0.16% | +800,000 | New | +$8.65M |
|
84
Lexicon Pharmaceuticals
LXRX
$400M
| $8.5M | 0.16% | +3,542,000 | New | +$8.5M |
|
85
10x Genomics
TXG
$1.74B
| $8.45M | 0.15% | 225,200 +185,400 | +466% | +$6.96M |
|
|
TSBX
86
DELISTED
Turnstone Biologics
TSBX
| $8.12M | 0.15% | 3,099,265 | – | – |
|
87
Perspective Therapeutics
CATX
$250M
| $7.74M | 0.14% | +6,505,800 | New | +$7.74M |
|
88
CytomX Therapeutics
CTMX
$336M
| $7.73M | 0.14% | +3,544,578 | New | +$7.73M |
|
89
Amicus Therapeutics
FOLD
$2.34B
| $6.72M | 0.12% | 570,300 -235,700 | -29% | -$2.78M |
|
90
Krystal Biotech
KRYS
$4.27B
| $6.61M | 0.12% | 37,166 -66,534 | -64% | -$11.8M |
|
91
Vir Biotechnology
VIR
$686M
| $6.48M | 0.12% | 640,000 +539,000 | +534% | +$5.46M |
|
92
Apollomics
APLM
$4.34M
| $6.42M | 0.12% | 8,565,456 | – | – |
|
93
InspireMD
NSPR
$102M
| $5.06M | 0.09% | 2,133,405 | – | – |
|
|
IMA
94
ImageneBio, Inc. Common Stock
IMA
$150M
| $5.03M | 0.09% | 3,539,358 | – | – |
|
|
ELEV
95
DELISTED
Elevation Oncology
ELEV
| $4.83M | 0.09% | 941,275 -558,725 | -37% | -$2.87M |
|
96
Progyny
PGNY
$2.04B
| $4.32M | 0.08% | +113,300 | New | +$4.32M |
|
97
Oric Pharmaceuticals
ORIC
$994M
| $3.95M | 0.07% | 287,100 -235,868 | -45% | -$3.24M |
|
98
Milestone Pharmaceuticals
MIST
$156M
| $3.58M | 0.07% | +2,000,000 | New | +$3.58M |
|
99
NextCure
NXTC
$13.5M
| $2.54M | 0.05% | 1,141,200 -1,569,813 | -58% | -$3.5M |
|
100
Bolt Biotherapeutics
BOLT
$9.85M
| $2.16M | 0.04% | 1,541,000 | – | – |
|